Precision Health
Begins Here

Turning biomarkers into breakthrough diagnostics and care pathways - starting with metabolic conditions.

We’re Not a Diagnostics Company

EazeBio is a digital health and biological intelligence platform.

Tests are tools. Understanding biology over time is the product. Instead of one-time snapshots, we focus on biological changing patterns and trends — the signals that matter before disease ever shows up.

One Platform, Two Experiences

{/* Left Line */} {/* Right Line */}
At Home
In Clinics &
Labs

Simple at-home tests, guided by our app.

Easy sample collection
Your smartphone acts as the reader
Clear, actionable results
Track trends over time
Wellness-focused and human-centered

For clinicians and partners, EazeBio supports professional workflows.

Fluorescent immunoassays
Dedicated reader
Structured biological data
Built for clinical environments

How EazeBio Works

1

Capture meaningful signals

We support multiple sensing methods — from lateral flow tests to advanced immunoassays — designed for different care settings.

Capture meaningful signals
2

Interpret with clarity

Our digital layer turns raw results into meaningful, human-readable insight — focused on trend, not alarm.

Interpret with clarity
3

Track what changes

Your biology isn't static. We help you see patterns over weeks and months, not just one moment in time.

Track what changes

Beyond Today’s Tests

In parallel, we are developing next-generation cortisol sensing technology based on advanced biosensing IP we have acquired and are co-developing with leading academic partners.

This work is focused on real-time stress biology and reflects where the platform is going — not just where it is today.

Built for the future Healthcare

Healthcare is shifting toward:

Prevention over reaction
Continuity over episodic care
Engagement over confusion

EazeBio is built for this future — empowering individuals and supporting clinicians with the same biological foundation.

future Healthcare Latest Articles

EazeBio and UC Santa Cruz partner to advance instrument-free diagnostic platform

EazeBio has announced a strategic partnership with the University of California, Santa Cruz (UC Santa Cruz) to advance and commercialize a groundbreaking instrument-free diagnostic platform. The collaboration will co-develop an innovative cortisol biosensor for stress and metabolic health testing, combining EazeBio’s expertise in affordable, scalable biotechnology with UC Santa Cruz’s deep research capabilities.

Learn More

Advanced Lateral Flow Conference 2025 (AFLC)

Finalist for ALFC 2025 Innovation Award — breakthrough science redefining healthcare with next-generation diagnostics.

Learn More

All India Institutes of Medical Sciences (AIIMS)

India is where the story of global health equity is being rewritten.Not in boardrooms — but in research labs, maternity wards, and mobile vans reaching the last mile.This past month, as part of Eazebio’s work with AIIMS, the Indian Red Cross Society, and community health programs across Bhopal, I’ve seen what innovation truly means: listening first, then building.

Learn More

11th Annual ADAM Global International Business Forum

Dubai is a true crossroads for innovation, investment, and global collaboration. Leaders from across industries gathered to shape the future of global healthcare and technology.

Learn More

We're proud to partner with Turquoise Biotechnologies as their Innovation Ally

This collaboration aligns perfectly with our shared vision—leveraging cutting-edge exosomes and biomarker insights to deliver hyper-personalized, targeted therapies that go beyond traditional approaches and truly revolutionize patient care

Learn More

Official partnership with the Golden State Obesity Society (GSOS) as an Innovation Partner

This partnership reflects our mission to move from one-size-fits-all care to personalized, biomarker-driven solutions that improve patient outcomes. And it showcases how our platform is built to adapt across key areas—from metabolic health and post-surgical recovery to autoimmune resilience and beyond

Learn More

PRECISION MEDICINE WORLD CONFERENCE (PMWC) -FEB 5-7

Discover how Eazebio is pioneering next-generation diagnostics to transform women's health. Founder Reem Mahrat highlights innovative approaches addressing unmet needs, from early detection to precision therapies, empowering women with cutting-edge solutions that redefine the future of personalized healthcare and advance equity in wellness worldwide.

Learn More

Historic Moment as Burj CEO Awards 2024 Awardees Light Up Times Square Billboard

A historic milestone in the realm of business excellence unfolded as the Burj CEO 2024 Awardees, representing over 40 global brands, illuminated the iconic Times Square billboard in New York. This moment etched itself not only in the annals of business recognition but also in the herts of all who bore witness to this grand tribute to achievement and leadership.

Learn More

LET THE GAINS BEGIN

At Eazebio, we are on a mission to empower women’s health, championing groundbreaking solutions that address needs too long overlooked. But this dream—this moment—is about more than milestones. It’s about people.

Learn More

"EazeBio is also developing next-generation biosensing technologies to support a deeper longitudinal understanding of stress biology."

EazeBio is a digital health and biological intelligence company.

Consumer offerings are wellness screening tools and are not intended to diagnose or treat disease. Professional workflows are designed for clinical and laboratory environments.